The leading cause of death in patients with psoriatic arthritis is cardiovascular disease, which is often linked in part to depression, anxiety, and other mental health issues. How do you assess your...
Are you familiar with the 2019 Update of the ACR/SAA/SRTN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis? Find out by taking our pop quiz!
Researchers have found that patients with OA may experience some restrictions in social participation. Do your patients with OA participate in social activities regularly?
The European League Against Rheumatism (EULAR) developed principles and points to consider to help patients achieve the best possible outcome by ensuring adherence to treatment. Tell us if you agree by...
EULAR updated its recommendations for treating rheumatoid arthritis with different therapeutic agents. Do you agree with its recommendation about initiating therapy for patients with RA?
For adults with ankylosing spondylitis or nonradiographic axial spondyloarthritis who have stable disease, what do the ACR/SAA/SRTN recommendations advise about combining and continuing therapeutic agents?...
When patients with AS or SpA continue to experience active disease despite taking NSAIDs, what subsequent therapies do the ACR/SAA/SRTN updated guideline on the treatment of AS and SpA recommend?
Immunoautonomics is a growing field and is leading to new and more-targeted immunotherapies. Do you think these advancements will predict treatment outcomes for patients with rheumatoid arthritis?
